Marcyrl Pharmaceutical Industries
Alzmenda 10 mg film-coated tablets
21 tablets
Alzmenda 10 mg contains memantine hydrochloride, a non-competitive NMDA receptor antagonist.
- Active ingredient
- MEMANTINE
- Pack size
- 21 tablets
- Form
- Tablets
- Brand
- Marcyrl Pharmaceutical Industries
- Manufacturer
- Marcyrl Pharmaceutical Industries (Mpi)
Description
It is used for the treatment of moderate to severe dementia in Alzheimer's disease.
Treatment should be given under a doctor's supervision.
Composition:
Each tablet contains:
- Memantine hydrochloride 10 mg
Excipients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, macrogol, titanium dioxide.
Properties:
Alzmenda is a remedy for dementia. Memantine is a non-competitive antagonist of glutamate NMDA receptors. It reduces the excessive stimulating effect of glutamate neurons and reduces the entry of Ca2+ into neurons, which may lower the risk of their destruction.
It has nootropic, cerebrovasodilating, antihypoxic and psychostimulating effects.
It improves weakened memory, increases the ability to concentrate, reduces fatigue and depression symptoms, and reduces skeletal muscle spasticity caused by diseases or brain damage.
Indications:
Moderate to severe dementia in Alzheimer's disease.
Storage:
Store at a temperature not higher than 30 °C.
Packaging:
Pack of 21 film-coated tablets.
The leaflet states that the cardboard box contains 1, 2 or 3 blisters of 7 tablets, with paper instructions for use.
Customer reviews
No reviews yet. Customers can rate a product after it is delivered.
